Anne Guillygomarc’h

1.6k total citations
24 papers, 963 citations indexed

About

Anne Guillygomarc’h is a scholar working on Hepatology, Hematology and Genetics. According to data from OpenAlex, Anne Guillygomarc’h has authored 24 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 8 papers in Hematology and 7 papers in Genetics. Recurrent topics in Anne Guillygomarc’h's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Iron Metabolism and Disorders (7 papers) and Hemoglobinopathies and Related Disorders (7 papers). Anne Guillygomarc’h is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Iron Metabolism and Disorders (7 papers) and Hemoglobinopathies and Related Disorders (7 papers). Anne Guillygomarc’h collaborates with scholars based in France and United States. Anne Guillygomarc’h's co-authors include Yves Deugnier, Romain Moirand, Fabrice Lainé, Pierre Brissot, Dominique Guyader, Bruno Turlin, Karim Boudjéma, Étienne Garin, M. Perrin and Éveline Boucher and has published in prestigious journals such as Hepatology, Journal of Hepatology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Anne Guillygomarc’h

23 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Guillygomarc’h France	16	487	450	292	230	161	24	963
D. K. George Australia	9	187 0.4×	484 1.1×	253 0.9×	195 0.8×	148 0.9×	15	859
Michel-Henry Mendler France	7	148 0.3×	321 0.7×	214 0.7×	159 0.7×	110 0.7×	9	654
Franco Capra Italy	15	385 0.8×	339 0.8×	240 0.8×	95 0.4×	122 0.8×	43	879
Laura Lisk United States	12	266 0.5×	63 0.1×	78 0.3×	67 0.3×	110 0.7×	17	1.3k
Shigeaki Takeda Japan	13	126 0.3×	131 0.3×	114 0.4×	31 0.1×	31 0.2×	35	443
Juan M. Mejía‐Vilet Mexico	19	126 0.3×	71 0.2×	40 0.1×	57 0.2×	17 0.1×	54	1.0k
Suporn Chuncharunee Thailand	20	49 0.1×	68 0.2×	947 3.2×	1.0k 4.4×	88 0.5×	97	1.5k
Cristina Arriens United States	19	123 0.3×	89 0.2×	49 0.2×	21 0.1×	31 0.2×	40	1.0k
W M Melia United Kingdom	17	687 1.4×	399 0.9×	25 0.1×	34 0.1×	12 0.1×	32	974
Timothy H. Carlson United States	7	33 0.1×	93 0.2×	285 1.0×	205 0.9×	134 0.8×	9	586

Countries citing papers authored by Anne Guillygomarc’h

Since Specialization

Citations

This map shows the geographic impact of Anne Guillygomarc’h's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Guillygomarc’h with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Guillygomarc’h more than expected).

Fields of papers citing papers by Anne Guillygomarc’h

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Guillygomarc’h. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Guillygomarc’h. The network helps show where Anne Guillygomarc’h may publish in the future.

Co-authorship network of co-authors of Anne Guillygomarc’h

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Guillygomarc’h. A scholar is included among the top collaborators of Anne Guillygomarc’h based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Guillygomarc’h. Anne Guillygomarc’h is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jézequel, Caroline, Pauline Houssel‐Debry, Thomas Uguen, et al.. (2017). Safety and Efficacy of 6-thioguanine as a Second-line Treatment for Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology. 16(2). 290–291. 19 indexed citations

Brunot, Angélique, Florence Le Roy, Samuel Le Sourd, et al.. (2017). Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib’s Toxicities in Hepatocellular Carcinoma. Cancer Nursing. 41(5). 418–423. 15 indexed citations

Beuzit, Luc, Julien Edeline, Vanessa Brun, et al.. (2016). Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT). European Journal of Radiology. 85(8). 1445–1452. 27 indexed citations

Brunot, Angélique, Florence Le Roy, Samuel Le Sourd, et al.. (2016). Les infirmières cliniciennes améliorent la gestion des toxicités des patients traités par sorafénib pour carcinome hépatocellulaire. Bulletin du Cancer. 103(11). 941–948. 3 indexed citations

Edeline, Julien, Laurence Crouzet, Boris Campillo‐Gimenez, et al.. (2015). Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. European Journal of Nuclear Medicine and Molecular Imaging. 43(4). 635–643. 67 indexed citations

Jézequel, Caroline, Edouard Bardou‐Jacquet, Isabelle Renard, et al.. (2015). P0709 : Survival of patients infected by chronic hepatitis c and f0f1 fibrosis at baseline after a 15 years follow-up. Journal of Hepatology. 62. S589–S589. 12 indexed citations

Edeline, Julien, Laurence Crouzet, Samuel Le Sourd, et al.. (2014). Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors. Cancer Chemotherapy and Pharmacology. 75(1). 215–219. 16 indexed citations

Garin, Étienne, Laurence Lenoir, Julien Edeline, et al.. (2013). Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. European Journal of Nuclear Medicine and Molecular Imaging. 40(7). 1057–1068. 142 indexed citations

Lan, Caroline Le, Anne Guillygomarc’h, Gérard Le Dréau, et al.. (2011). A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse. Journal of Hepatology. 56(2). 334–340. 24 indexed citations

10.

Boucher, Éveline, Guillaume Bouguen, Étienne Garin, et al.. (2008). Adjuvant Intraarterial Injection of ¹³¹I-Labeled Lipiodol After Resection of Hepatocellular Carcinoma: Progress Report of a Case-Control Study with a 5-Year Minimal Follow-up. Journal of Nuclear Medicine. 49(3). 362–366. 23 indexed citations

11.

Guillygomarc’h, Anne, M. Perrin, Fabrice Lainé, et al.. (2006). Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases. Hepatology. 44(2). 472–477. 141 indexed citations

12.

Lainé, Fabrice, Jean‐Michel Reymann, François M. M. Morel, et al.. (2006). Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial. Alimentary Pharmacology & Therapeutics. 24(8). 1207–1213. 8 indexed citations

13.

Raoul, Jean‐Luc, Éveline Boucher, Damien Olivié, et al.. (2005). Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: Results of phase II trial. International Journal of Radiation Oncology*Biology*Physics. 64(3). 745–750. 10 indexed citations

14.

Lainé, Fabrice, Claude Bendavid, Romain Moirand, et al.. (2004). Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepatology. 39(6). 1639–1646. 48 indexed citations

15.

Guillygomarc’h, Anne, et al.. (2003). Circadian variations of transferrin saturation levels in iron‐overloaded patients: implications for the screening of C282Y‐linked haemochromatosis. British Journal of Haematology. 120(2). 359–363. 16 indexed citations

16.

Lainé, Fabrice, Anne Guillygomarc’h, Karim Boudjéma, et al.. (2002). Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. Journal of Hepatology. 36(1). 93–98. 123 indexed citations

17.

Guillygomarc’h, Anne, Romain Moirand, Fabrice Lainé, et al.. (2001). Venesection therapy of insulin resistance-associated hepatic iron overload. Journal of Hepatology. 35(3). 344–349. 75 indexed citations

18.

Turlin, Bruno, Michel Mendler, Romain Moirand, et al.. (2001). Histologic Features of the Liver in Insulin Resistance–Associated Iron Overload. American Journal of Clinical Pathology. 116(2). 263–270. 103 indexed citations

19.

Brissot, Pierre, D. Guyader, Olivier Loréal, et al.. (2000). Clinical aspects of hemochromatosis. Transfusion Science. 23(3). 193–200. 31 indexed citations

20.

Brittenham, Gary M., Günter Weiß, Pierre Brissot, et al.. (2000). Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism. Hematology. 2000(1). 39–50. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact